Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens
About this trial
Mitral insufficiency (MI) accounts for 24% of adult valvulopathies and affects 7% of subjects older than 75 years. They are the second leading cause of valvulopathy in Europe. The most common etiology is the associated valvular prolapse. Mitral surgery remains the reference treatment for symptomatic MI. The success of this procedure depends on the mitral valve geometry and the location of the prolapse. The site of the prolapse, whether monovalvular, localized to the posterior or anterior leaflet, or bivalvular, influences the possibilities and probably the long-term results of the plasty.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients operated between 1988 and 2011
Presence of a valvular prolapse diagnosed by echocardiography
Possibility of a complete clinical evaluation at the time of the initial echocardiography
Disqualifiers
Ischemic MI (including papillary muscle rupture)
Presence of significant aortic valvulopathy, mitral valvular stenosis or congenital disease
History of cardiac surgery
Trial population
Study of the long-term survival of patients who have had mitral valve prolapse for mitral valve prolapse in Amiens according to the location of the prolapse
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Survival defines as the time between the date of surgery and the death or date of the last news
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov